The U.S. health care system has the best access to the most innovative therapies in the world. Many people forget this aspect of health care, until they are sick. Many health care proposals could dampen competition among technology developers and health care delivery organizations, meaning that fewer new medical advances will occur. There is evidence that this is already happening in Europe, where price controls are a`standard tool for controlling health care costs.
Some experts believe that innovation can come from government research and academia, rather than solely from the market. While many basic research findings do come out of academia, turning
those into products that can be used to treat people has always been
done almost exclusively by for-profit corporations (although a growing
number of non-profits are involved in drug development).
Featured Podcast
Current State and Prospects for Consumer Directed Health Care Kim D. Slocum, President of KDS Consulting speaks with Malorye Allison, editor-in-chief of ReformPlans.com.
